Synthetic peptides derived from human and bovine lactoferricin, as well as tritrpticin sequences, were assayed for antimicrobial activity against wild-type Escherichia coli and LPS mutant strains. Antimicrobial activity was only obtained with peptides derived from the bovine lactoferricin sequence and peptides corresponding to chimeras of human and bovine sequences. None of the peptides corresponding to different regions of native human lactoferricin showed any antimicrobial activity. The results underline the importance of the content of tryptophan and arginine residues, and the relative location of these residues for antimicrobial activity. Results obtained for the same assays performed with LPS mutants suggest that lipid A is not the main binding site for lactoferricin which interacts first with the negative charges present in the inner core. Computer modelling of the most active peptides led to a model in which positively charged residues of the cationic peptide interact with negative charges carried by the LPS to disorganise the structure of the outer membrane and facilitate the approach of tryptophan residues to the lipid A in order to promote hydrophobic interactions.
Introduction
A wide variety of organisms produce antimicrobial peptides as a primary innate immune strategy [1] . Typically, these peptides are relatively short (less than 100 amino acids), positively charged, amphiphilic and are reported to be active against bacteria, fungi, viruses and protozoa [2] . Their modes of action can vary and are not fully understood, but their main site of action is thought to be the cell membrane. The enterobacterial OM bilayer consists of an inner monolayer containing phospholipids and an outer monolayer that is mainly lipopolysaccharide (LPS) [3] .
Different mechanisms have been proposed for the uptake of antibiotics across the membrane [4, 5] . Studies on the interaction of antimicrobial peptides with model phospholipid membranes have revealed low affinity for zwitterionic phospholipids [6] . After initial insertion into the membrane, by adsorption of the unfolded form on the surface of the negatively charged phospholipid membrane, their positive charges are partially neutralised by the negative charges of the phospholipids headgroups. Hydrophobic forces promote the formation of a stable ahelical structure, driving the peptide further into the monolayer [7] . This mechanism suggests that the different susceptibilities of wild-type and deep rough mutant stains to hydrophobic antibiotics result from differences in the organisation of the outer membrane and in the accessibility of the phospholipid bilayer regions [4] . In addition, the decrease of protein content of the outer membrane found in some rough mutants is compensated for by an increase in phospholipid [8] , where such exposed phospholipid bilayer regions would allow the rapid penetration of hydrophobic molecules [9] .
Hydrophobicity, cationicity and secondary structure have been implicated in the antimicrobial effect [10] . Human and bovine lactoferricins (LfcinH and B) are antimicrobial peptides arising from pepsin cleavage of human and bovine lactoferrin, respectively [11] . A region of 11 residues in LfcinB has been identified as essential for antibacterial effect [12] . Recently, two regions in LfcinH covering residues 1-5 and 19-31 were found to be important for antimicrobial activity [13] . Interaction between LPS and both lactoferricins has been investigated, using a synthetic octadecapeptide corresponding to residues 20-37 in LfcinH, and the whole LfcinB. In both cases, the 28-34 loop region of LfcinH and its homologous region in LfcinB were found to be involved in LPS binding [14] .
In the present work, the antimicrobial activities of a variety of peptides, including human and bovine lactoferricin-derived peptides and tritrpticin, towards wildtype and outer-membranes mutant strains of Escherichia coli are compared, to clarify the role of LPS in preventing interaction with phospholipids and the mode of action of peptides on the outer membrane.
Materials and methods

Bacterial strains
The peptides were assayed against several strains of E. coli with structurally different LPS. The strains can be grouped according to the region of their LPS affected (Fig. 1) . The relevant genotype of the K12 strains is as follows: W3110 (wild-type E. coli), D21 (rfa+), D21e19 (rfa-11), D21e7 (rfa-1), D21f1 (rfa-1, rfa-21) and D21f2 (rfa-1, rfa-31). D21 parental strains and derivative mutants were obtained from the E. coli Genetic Stock Center (cgsc.biology.yale.edu/top.html). These strains have been characterised and their LPS composition deduced after gas chromatography analysis of carbohydrates [15] [16] [17] [18] . Lipid A mutant strains MLK43, 986 and 1067 were kindly donated by Professor C.R. Raetz (Duke University Medical Center, Durham, NC). These strains are defective in late acylations of lipid A and are knockout mutants: MLK53 (htrB1::Tn10), MLK1067 (msbB::Xcam) and MLK986 (htrB1::Tn10 msbB::Xcam). MLK1067 lacks the msbBencoded (Kdo) 2 -(lauroyl)-lipidIV A myristoyltransferase and produces penta-acylated lipid A that is devoid of the myristic acid residue. MLK53 and MLK986 are thermosensitive and grow well at 30°C but poorly at 37°C. They lack the htrB-encoded (Kdo) 2 -lipidIV A lauroyltransferase and produce penta-acylated lipid A that is devoid of the lauric acid residue. The msbB htrB double mutant MLK986 produces lipid A that lacks both the lauric acid and myristic acid residues. E. coli B strain WA834 (WA707 DompT504) is derived from the wild-type E. coli B WA707. Cultures were grown overnight in Mueller Hinton Broth medium (Difco) at 37°C, except strains MLK53, MLK986 and MLK1067 which are thermo-sensitive and were therefore grown at 32°C.
Cationic peptides
The peptides used in this study (Table 1) can be divided in three groups: group A, based on the human lactoferricin sequence (Lfcin H), group B, based on the bovine lactoferricin sequence (Lfcin B) and group C, comprising the more active tritrpticin and tritrpticin (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Peptides were synthesised by Advanced Biotechnology Centre (ABC) (Imperial College London) using an automatic synthesiser and analysed by HPLC. They were stored in their freeze-dried form at )20°C and dissolved on the day of use, as described in the method of Hancock (www.cmdr.ubc.ca/bobh/ MIC.htm).
Minimal bactericidal concentration measurement
Minimal bactericidal concentrations (MBCs) ( Table 2) were obtained using the recently modified Fig. 1 . LPS-mutant phenotypes. The four mutants derived from the parental strain D21 carry a mutation in rfa. D21e19 is deficient in component of the O-antigen, D21e7 is galactoseless, D21ef1 is a glucose-and heptose-bound phosphateless LPS strain, and D21f2 is a heptoseless LPS strain. The lipid A msbB mutant of MLK53 lacks the myristic acid residue 2, the htrB mutant lacks the lauric acid residue 4 and the msbB htrB double mutant lacks both residues 2 and 4. method used in the Hancock laboratory (www.cmdr. ubc.ca/bobh/MIC.htm) based on the classical microtitre broth dilution recommended by the National Committee of Laboratory Safety and Standards (NCLSS).
Comparative modelling
Peptide modelling was performed using Modeller 4 on a Silicon Graphic System. Tertiary structure predictions were based on sequence alignment with the bovine lactoferricin sequence and its NMR-determined 3D structure (1LFC) available from the Protein Data Bank (PDB).
Results
Antimicrobial activity of peptides against wild-type strains
Peptides in Group A are based on four different regions (1-4) of the whole LfcinH (Table 1) as well as regions 5 and 6 overlapping partly regions 2 and 3, and 3 and 4, respectively. No antimicrobial activity was detected for any of the regions taken separately and based on the non-modified sequence (Table 2) .
Antimicrobial activity (Table 2 ) was obtained for two peptides LfcinH(21-31)5s (A10) and LfcinH(19-31)6s Table 1 Peptide investigated 
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All peptides were synthesised with L amino acids. (A) Peptides derived from human lactoferricin (LfcinH); (B) Peptides derived from bovine lactoferricin (LfcinB). Regions (1) (2) (3) (4) (5) and (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) are framed; region (29) (30) (31) (32) (33) (34) (35) , underlined, is the putative LPS binding region; peptides are numbered according to the corresponding residues in human lactoferrin; substitutions are in bold; for a single substitution, residue number is indicated followed by the replacement residue; for multiple substitutions, only the number of substitution (s) is indicated.
(A11) which were based on region 4 of human lactoferricin. They both contain five substitutions chosen from the bovine lactoferricin sequence. A higher MBC was obtained for the peptide A11 which contains two additional proline residues inserted between each tryptophan residue and their neighbouring arginine residue.
In Group B, peptides based on the bovine lactoferricin sequence (LfcinB), only peptides covering the whole region from 17 to 31 displayed some antimicrobial activity, with an increase in MBC after substitutions W24A and L29A were made.
Apart from tritrpticin, only peptides containing a net positive charge of at least +5 and at least 1 tryptophan showed some antimicrobial activity. Only native tritrpticin shows a net charge of only +4 but possesses three tryptophan residues. It seems that a factor common to all the active peptides is a value of 6 for the sum of net charge and tryptophan residues.
Comparative modelling
In order to predict the structural effect following substitution(s) or insertion(s) of amino acid residues in the peptides, the 3D structure of peptides A10 and B1 was predicted and compared with their respective mutated forms peptides A11 and B2 (Fig. 2) . The predicted structures of peptides B1 and B2 could be superimposed with no differences in overall structure, suggesting that the decrease in antimicrobial activity was due to the loss of tryptophan residue. The opposite effect was observed with peptides A10 and A11 whose models could not be superimposed. The difference in antimicrobial activity, despite the same number of charges and tryptophan residues within both peptides, can only be due to structural changes following the insertion of proline residues. This result suggests the importance of a position of the tryptophan relative to the arginine residues.
Antimicrobial activity of peptides against LPS-lipid A mutant strains
A slight decrease in MBC (Table 2) was observed between the three penta-and tetra-acylated lipid A mutant strains and the wild-type E. coli for all the active peptides, with an inverse relationship between antimicrobial activity and the number of fatty acids. In addition, a low antimicrobial activity was obtained with three other peptides derived from the region (18-26) of LfcinH with the three mutants. None of the native peptides displayed any activity when tested against these strains. This suggests that the alteration of the very tight fatty acid packing of the hexa-acylation of lipid A results in an increase in fluidity that could facilitate hydrophobic interactions as described with hydrophobic reagents [14] . Similarly, a slight increase in antimicrobial activity was observed with peptides A11 and B2 for OmpT À WA834 indicating that OmpT is probably not directly involved in Lfcin binding, as suggested for other Omp proteins [20] . This effect might be the result of the increase in concentration of negative charges on the outer membrane as suggested by Nikaido and Nakae [4] . Peptides showing antimicrobial activity are in bold.
Antimicrobial activity of peptides against LPScarbohydrate mutant strains
The peptides were assayed for antimicrobial activity with four E. coli strains of rough phenotype having mutations in the LPS other than in lipid A ( Table 2 ). The mutants derived from the parental strain D21 have lost progressively increasing amounts of sugar residues which result in shorter LPS, as indicated in Fig. 1 . Antimicrobial effects were observed with the same peptides as with the wild-type but with differing MBCs. The changes detected were not proportional to the decrease in LPS chain length. For the first two mutants, D21e19 and D21e7, a decrease in MBC, indicating an increase in sensitivity, was seen. The two other mutants with shorter LPS presented the opposite effect. An increase in MBC was observed with D21f1, even with tritrpticin. For the last heptoseless mutant strain, D21f2, an MBC higher than with the wild-type, but lower than for D21f1, was observed. This variation in MBC, non-proportional to the LPS chain length, suggests a complex mechanism.
Discussion
The mechanism(s) of action of antimicrobial peptides on their natural targets are poorly understood. It is thought that most peptides bind ionically to the surface of Gram negative bacteria and then insert into the membrane outer leaflet [1] . Studies on LfcinB have identified several parts of the sequence to be involved in antimicrobial activity [19, 21] , emphasizing the importance of the WQW motif and identifying RRWQWR as the minimum active sequence [20, 22] . Sequence modifications have demonstrated that single amino acid substitutions in longer peptides can alter the Gram positive/ negative selectivity, enhance or abolish activity [22] [23] [24] . In addition, as well as structure/activity, quantitative relationships have been proposed [25] . Less is known of the mode of action of LfcinH. Activity of truncated LFcinH has been shown by several groups [11, 13, [26] [27] [28] and together these data suggest that the region forming a helix in the native protein (peptide A10) is important. Lfcin contains a short hydrophobic sequence flanked by cationic sequence, similar to many other antimicrobial peptides including the considerably more potent tritrpticin [20, 27, 29, 30] .
In the present study, we have attempted to determine which of the components of LPS were interacting with the cationic peptides. To this end, a group of peptides were assayed against wild-type and a series of LPS mutants strains. We have tested peptides containing the putative LPS binding site [14, 31] (peptides A1-3 and A10-16), peptides with variations in the FQW hydrophobic core (peptide A5-9), a hybrid bovine/human sequence of predicted increased potency (peptide A12) and its analogue with proline insertions between charge and hydrophobic core to mimic the kinked structure of tritrpticin (A13), and a series of charged peptides lacking the hydrophobic core but retaining the LPS binding site (peptides A14-16). These peptides were compared to bovine sequences and improved bovine sequences (peptides B1-3) including the hydrophobic ÔactiveÕ core alone (peptides B4) and tritrpticin positive controls (peptides C1-2). (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) 6s (A11), respectively. Tryptophan residues are in red, and positively charged arginine and lysine residues are in green; inserted proline residues are in blue. Ribbon representation has been superimposed on the backbone; comparison of (a) and (b), corresponding to peptides B1 and B2, respectively, shows that the two peptides are superimposable, implying that substitution W24A did not create any structural alteration. Comparison of (d) and (c), corresponding to peptides A10 and A11, respectively, indicate that major structural alterations followed the insertion of the two proline residues with a different spatial distribution of the positive charges relatively to the tryptophan residues.
Many peptides proved unexpectedly inactive, possibly because the wild-type target strain shows relative resistance to these relatively weak peptides. Highly charged peptides known to bind to LPS exerted no activity (peptides A1-3). However, modified LfcinH and LfcinB and tritrpticin all exhibited sufficient activity to allow differences in activity with the mutants to be detected.
Only peptides containing a sum of tryptophan residues and net positive charges of at least 6 showed some antimicrobial activity. The importance of the tryptophan was emphasised by the decrease in potency after substitution of Trp8 in peptide B1 despite the predicted conservation in overall structure (Fig. 2(a) and (b) ). The decrease in potency between peptides A10 and A11 (Fig. 2(c) and (d) ) suggests a link between both types of interaction with the membrane. The insertion of proline residues affects neither the net charge nor the tryptophan content of the peptide but only changes their relative position. As shown in Fig. 2(d) , such insertions are predicted to alter the tertiary structure of the peptide and further separate positively charged residues from tryptophans. This interdependence of both kinds of interactions, electrostatic and hydrophobic, for antimicrobial activity was confirmed by results obtained with the LPS mutants.
Lipid A mutants did not show a major increase in susceptibility to any peptides suggesting that in contrast to the effect observed with hydrophobic reagents, the tight fatty acid packing in lipid A is not the primary site of interaction for lactoferricin. The slight decrease in MBC could be due to a less rigid pentaand tetra-acylated lipid A, producing a more fluid outer membrane with increased hydrophobic interactions.
The successive increase and decrease in sensitivity observed with successive shortening of LPS suggests electrostatic interactions between the peptide basic residues and the negative charges of LPS. Shortening of O-antigen and part of the outer core, strains D21e19 and D21e7, respectively, allows unmasking of the negative charges carried by the phosphate groups in the inner core increasing the ionic interaction. It is interesting to note that the increase in susceptibility to cationic peptides for the first two mutant strains D21e19 and D21e7 is contrary to the increase in ampicillin resistance previously described [17] , which suggests a different mechanism of action. Further shortening of LPS in strains D21f1 and D21f2 results in the loss of most of the negative charges and consequently less interaction with the cationic peptides. The compensation of the loss of further electrostatic interaction, with the heptoseless mutant D21f2, by a facilitated access to the lipid A and stronger hydrophobic interactions, could be responsible for the slight increase in susceptibility compared to D21f1.
These results support a two-step mechanism where positive residues of the cationic peptide first interact with negative charges carried by the LPS; the resulting disorganisation of the structure of the outer membrane then enables the tryptophan residues to approach the lipid-A for hydrophobic interactions, leading to further penetration of the outer membrane. This mechanism can also account for the difference in MBC between peptides B1 and B2 (Fig. 2(a) and (b) ), since only the removal of the tryptophan residue, and therefore the decrease in hydrophobic interaction with no structural alteration, can be responsible for the increase in MBC.
As suggested by Ulvatne and Vorland [24] , the disruption of the outer membrane structure is unlikely to be the main factor leading to cell death. The susceptibility of Gram negative bacteria to cationic peptides has been proposed to be associated with factors that facilitate the transport of the peptide across the outer membrane, such as the magnitude and location of the LPS charge, the concentration of LPS in the outer membrane, outer membrane molecular architecture and the presence or absence of the O-antigen side chain [10] . Based on the mechanism suggested above, cationic peptides should not be taken as antimicrobial agents but probably more as disorganizing or permeabilizing agents that could increase susceptibility to more efficient antibiotics. To this aim more studies should be done with peptides in conjunction with hydrophobic antibiotics.
